Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM)
Condition: Functional Mitral Regurgitation Intervention: Drug: dapagliflozin Sponsors: Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University; Jieyang People's Hospital; Eighth Affiliated Hospital, Sun Yat-sen University; Affiliated Hospital of Guangdong Medical University; Yuebei People's Hospital; Zhongshan People's Hospital, Guangdong, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM)
Condition: Functional Mitral Regurgitation Intervention: Drug: dapagliflozin Sponsors: Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University; Jieyang People's Hospital; Eighth Affiliated Hospital, Sun Yat-sen University; Affiliated Hospital of Guangdong Medical University; Yuebei People's Hospital; Zhongshan People's Hospital, Guangdong, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM)
Condition: Functional Mitral Regurgitation Intervention: Drug: dapagliflozin Sponsors: Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University; Jieyang People's Hospital; Eighth Affiliated Hospital, Sun Yat-sen University; Affiliated Hospital of Guangdong Medical University; Yuebei People's Hospital; Zhongshan People's Hospital, Guangdong, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM)
Condition: Functional Mitral Regurgitation Intervention: Drug: dapagliflozin Sponsors: Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University; Jieyang People's Hospital; Eighth Affiliated Hospital, Sun Yat-sen University; Affiliated Hospital of Guangdong Medical University; Yuebei People's Hospital; Zhongshan People's Hospital, Guangdong, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM)
Condition: Functional Mitral Regurgitation Intervention: Drug: dapagliflozin Sponsors: Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University; Jieyang People's Hospital; Eighth Affiliated Hospital, Sun Yat-sen University; Affiliated Hospital of Guangdong Medical University; Yuebei People's Hospital; Zhongshan People's Hospital, Guangdong, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM)
Condition: Functional Mitral Regurgitation Intervention: Drug: dapagliflozin Sponsors: Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital of Guangzhou Medical University; Jieyang People's Hospital; Eighth Affiliated Hospital, Sun Yat-sen University; Affiliated Hospital of Guangdong Medical University; Yuebei People's Hospital; Zhongshan People's Hospital, Guangdong, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 8, 2023 Category: Research Source Type: clinical trials
